Cancer has traditionally been treated based on where it originates in the body, with different therapies for different types. But now, researchers are shifting toward a more personalized approach, focusing on the genetic makeup of tumors. This shift holds great promise, but it can be taken even further. By uncovering the complex networks of genetic interactions within cancer cells, we can identify new vulnerabilities and improve how we target them. Tumors are complex and vary from patient to patient, which means there’s no one-size-fits-all treatment. However, by understanding the genetic pathways that cancer cells rely on to survive and grow, we can gain a clearer picture of how to stop them. As we refine this understanding, we’ll be able to create more precise and effective therapies, offering new hope for even the most aggressive cancers. By continuing to explore these genetic networks, we’re moving closer to transforming cancer treatment—and perhaps even finding a cure. Dr. Franco J. Vizeacoumar (PhD) is a senior scientist at Saskatchewan Cancer Agency and associate professor of oncology at the University of Saskatchewan. He earned his PhD in cell biology from the University of Alberta and completed postdoctoral training at the University of Toronto. His research focuses on identifying novel cancer drug targets, using genetic principles such as synthetic lethality. His broader body of work spans genome-wide unbiased screens, machine learning approaches, drug repurposing platforms and mechanistic studies to identify these targets. Vizeacoumar has contributed extensively to the academic community by co-editing two textbooks, publishing over 70 peer-reviewed articles, and serving on numerous national grant review panels and the editorial boards of multiple journals. His research is supported by leading funding agencies, including CIHR, NSERC, CRS, SCA, SHRF, CFI, TFRI, and the Be Like Bruce organization. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx